FMR LLC

Holdings History for Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Symbol: IMVT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 14,729,555 shares
Security Ownership %: 8.4%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Immunovant, Inc. Common Stock, par value $0.0001 per share (IMVT)

05 Nov 2025 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 14,729,555 shares of Immunovant, Inc. Common Stock, par value $0.0001 per share (IMVT). This represents 8.4% ownership of the company. In their previous filing dated 07 Mar 2025, FMR LLC had reported owning 17,078,093 shares, indicating a decrease of +14%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
FMR LLC	8.4%	-17%	$237,440,423	14,729,555	-2,348,538	-14%	$16.12	13G/A	30 Sep 2025	05 Nov 2025, 11:35
FMR LLC	10%		$259,928,578	17,078,093			$15.22	13G/A	28 Feb 2025	07 Mar 2025, 10:01

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0%	$431,904,967	16,990,754	+2,261,199	+15%	$25.42	Q4 2025
30 Sep 2025	0.01%	-0%	$237,440,423	14,729,555	-3,869,640	-21%	$16.12	Q3 2025
30 Jun 2025	0.02%	+0%	$297,587,112	18,599,195	+1,358,160	+7.9%	$16.00	Q2 2025
31 Mar 2025	0.02%	+0%	$294,649,289	17,241,035	+4,143,120		$17.09	Q1 2025
31 Dec 2024	0.02%	+0%	$324,435,352	13,097,915	+560,344	+4.5%	$24.77	Q4 2024
30 Sep 2024	0.02%	+0%	$357,446,159	12,537,571	+2,053,688	+20%	$28.51	Q3 2024
30 Jun 2024	0.02%	+0.01%	$276,774,522	10,483,883	+2,827,938	+37%	$26.40	Q2 2024
31 Mar 2024	0.02%	-0%	$247,363,595	7,655,945	-219,877	-2.8%	$32.31	Q1 2024
31 Dec 2023	0.03%	+0%	$331,808,380	7,875,822	+127,276	+1.6%	$42.13	Q4 2023
30 Sep 2023	0.03%	+0.01%	$297,466,681	7,748,546	+2,494,678	+47%	$38.39	Q3 2023
30 Jun 2023	0.01%	+0%	$99,665,876	5,253,868	+1,106,899	+27%	$18.97	Q2 2023
31 Mar 2023	0.01%	+0%	$64,319,490	4,146,969	+1,658,836	+67%	$15.51	Q1 2023
31 Dec 2022	0%	+0%	$44,164,361	2,488,133	+2,487,410	+344040%	$17.75	Q4 2022
30 Sep 2022	0%	0%	$4,000	723	+34	+4.9%	$5.53	Q3 2022
30 Jun 2022	0%	0%	$3,000	689	-204	-23%	$4.35	Q2 2022
31 Mar 2022	0%	0%	$5,000	893	+893	NEW	$5.60	Q1 2022
31 Dec 2020		-0%	$0	0	-200,000	-100%	$27.20	Q4 2020
30 Sep 2020	0%	+0%	$7,038,000	200,000	+200,000	NEW	$35.19	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.